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SCIENTIFIC OPINION 
Scientific Opinion on the safety and efficacy of Rovabio
® Excel (endo-
1,3(4)-beta-glucanase and endo-1,4-beta-xylanase) as a feed additive for 
lactating sows
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Rovabio
® Excel is a preparation of endo-1,3(4)-beta-glucanase and endo-1,4-beta-xylanase that is intended to be 
used as a feed additive for lactating sows, at a dose of 1 500 glucanase U and 1 100 xylanase U/kg feed, in order 
to minimise the mobilisation of body reserves of sows during lactation. The European Food Safety Authority 
issued an opinion on the safety and efficacy of Rovabio
® Excel as a feed additive for chickens and turkeys for 
fattening, laying hens, piglets (weaned) and pigs for fattening, ducks, guinea fowl, quails, geese, pheasants and 
pigeons. The full description of the formulations, manufacturing processes, purity, stability and homogeneity of 
the product is given in that assessment. The FEEDAP Panel considers that the safety aspects, other than for the 
new target species, are covered in the previous assessment and would not be affected by the extension of use 
requested. The results of a tolerance study showed that 200-fold the recommended dose was tolerated well by the 
sows when offered for a period of seven weeks, including gestation and lactation. Therefore, the Panel concludes 
that the recommended dose is safe in lactating sows. The Panel cannot conclude on the efficacy of Rovabio
® 
Excel from the available efficacy data. 
© European Food Safety Authority, 2014 
KEY WORDS 
zootechnical additive, digestibility enhancers, glucanase, xylanase, sows, safety, efficacy 
                                                       
1  On request from European Commission, Question No EFSA-Q-2011-00881, adopted on 20 May 2014. 
2  Panel  members:  Gabriele  Aquilina,  Vasileios  Bampidis,  Maria  De  Lourdes  Bastos,  Lucio  Guido  Costa,  Gerhard 
Flachowsky, Mikolaj Antoni Gralak, Christer Hogstrand, Lubomir Leng, Secundino López -Puente, Giovanna Martelli, 
Baltasar Mayo, Fernando Ramos, Derek Renshaw, Guido Rychen, Maria Saarela, Kristen Sejrsen, Patrick Van Beelen, 
Robert John Wallace and Johannes Westendorf Correspondence: FEEDAP@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Enzymes, including Paul Brantom, 
Noël Dierick and Ingrid Halle, for the preparatory work on this scientific opinion. 
 Rovabio
® Excel for sows 
 
EFSA Journal 2014;12(6):3722  2 
SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy  of  Rovabio
®  Excel  (endo-1,3(4)-beta-glucanase  and  endo-1,4-beta-xylanase)  as  a  feed 
additive for lactating sows, at a dose of 1 500 glucanase U and 1 100 xylanase U/kg feed, in order to 
minimise the mobilisation of body reserves of sows during lactation. The additive is intended to be 
classified as a zootechnical additive (functional group: digestibility enhancers). 
The European Food Safety Authority (EFSA) issued an opinion on the safety and efficacy of Rovabio
® 
Excel as a feed additive for chickens and turkeys for fattening, laying hens, piglets (weaned) and pigs 
for fattening, ducks, guinea fowl, quails, geese, pheasants and pigeons. The full description of the 
formulations, manufacturing processes, purity, stability and homogeneity of the product is given in 
that assessment. The FEEDAP Panel considers that the safety aspects, other than for the new target 
species, are covered in the previous assessment (EFSA FEEDAP Panel, 2013) and would not be 
affected by the requested extension of use. Therefore, the present opinion focused only on the safety 
and efficacy of this enzyme preparation for the new target species. 
The results of a tolerance study showed that 200-fold the recommended dose was tolerated well by the 
sows when offered for a period of seven weeks, including gestation and lactation. Therefore, the Panel 
concludes that the recommended dose is safe in lactating sows. 
The results of a meta-analysis showed a significant but very limited reduction of body weight loss in 
lactating sows fed Rovabio
® Excel at the recommended dose given at least one week before farrowing 
and  during  the  whole  lactation  period,  which  may  indicate  some  potential  of  the  additive  to  be 
efficacious.  However,  the  FEEDAP  Panel  questions  the  biological/physiological  relevance  of  this 
finding, especially considering that the impact on the following weaning to oestrus interval and on the 
next reproductive cycle of the sows was not measured. In one trial, a significant increase was noted in 
the  faecal  digestibility  of  energy  from  the  diet  containing  Rovabio
®  Excel  at  a  higher  dose  than 
recommended. The FEEDAP Panel cannot conclude on the efficacy of Rovabio
® Excel in lactating 
sows from the data currently available. Rovabio
® Excel for sows 
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BACKGROUND 
Regulation  (EC)  No  1831/2003
4  establishes the rules  governing the Community authorisation of 
additives for use in animal nutrition. In  particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from ADISSEO SAS
5 for authorisation of the product 
Rovabio
® Excel, endo-1,3(4)-beta-glucanase and endo-1,4-beta-xylanase, when used as a feed additive 
for lactating sows (category: zootechnical additive; functional group: digestibility enhancers) under 
the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6  According  to  Article  8  of  that 
Regulation, EFSA, after verifying the particulars and documents submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the applicat ion were considered 
valid by EFSA as of 4 November 2011. 
The additive Rovabio
®  Excel  is  a  preparation  of  endo-1,3(4)-beta-glucanase  and  endo-1,4-beta-
xylanase  produced  by  a  strain  of  Penicillium  funiculosum  (Talaromyces  versatilis  sp.  novus  IMI 
378536). The additive is authorised for all poultry species, weaned piglets and pigs for fattening.
7 The 
Scientific Committee on Animal Nutrition (SCAN) issued an opinion on the use of Rovabio
® Excel as 
a feed additive for pigs for fattening, chickens for fattening, laying hens and turkeys for fattening (EC, 
1996 updated in 2002). Two other opinions were adopted by SCAN one on the safety of the product 
for ducks and one on the safety for piglets (weaned) (EC, 2003a, and 2003b). The European Food 
Safety  Authority  (EFSA  FEEDAP  Panel,  2013)  issued  an  opinion  on  the  safety  and  efficacy  of 
Rovabio
® Excel as a feed additive for chickens and turkeys for fattening, laying hens, piglets (weaned) 
and pigs for fattening, ducks, guinea fowls, quails, geese, pheasants and pigeons. 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product 
Rovabio
®  Excel  (endo-1,3(4)-beta-glucanase  and  endo-1,4-beta-xylanase),  when  used  under  the 
conditions described in Table 1. 
                                                       
4  Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  ADISSEO, 10 place du Général de Gaulle, 92160, Antony, France. 
6  EFSA Dossier reference: FAD-2011-0026. 
7  Commission Implementing Regulation (EU) No 290/2014 of 21 March 2014 concerning the authorisation of a preparation 
of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase produced by Talaromyces versatilis sp. nov. IMI CC 378536 as 
a feed additive for poultry, weaned piglets and pigs for fattening and amending Regulations (EC) No 1259/2004, (EC) No 
943/2005, (EC) No 1206/2005 and (EC) No 322/2009 (holder of the authorisation Adisseo France S.A.S.).  OJ L 87, 
22.3.2014, p. 84. Rovabio
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Endo-1,3(4)-beta-glucanase EC 3.2.1.6  
Endo-1,4-beta-xylanase EC 3.2.1.8 
Registration number/EC No/No 
(if appropriate)  E 1604 
Category(ies)  of additive  Zootechnical additives 
Functional group(s) of additive  Digestibility enhancers 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Preparation of endo-1,3(4)-beta-
glucanase and endo-1,4-beta-
xylanase produced from Penicillium 
funiculosum (PF8/403 IMI 378536) 
having a minimum activity of: 
 
- Powder forms (coated or not) 
Endo-1,3(4)-beta-glucanase : 
min 30 000 viscometric units/g 
(viscometric Barley β - glucan 
method) 
OR 
min. 4 300 DNS Units/g (DNS 
barley beta-glucan method) 
 
Endo-1,4-beta-xylanase: 
min. 22 000 viscometric units/g 
(viscometric wheat arabinoxylan 
method)  
OR 
min. 3 200 DNS units/g (DNS 
birchwood xylan method) 
 
- Liquid forms 
Endo-1,3(4)-beta-glucanase : 
min 7 500 viscometric units/mL 
(viscometric barley β - glucan 
method) 
OR 
min. 1 075 DNS units/mL (DNS 
barley β-glucan method) 
 
Endo-1,4-beta-xylanase: 
min. 5 500 viscometric units/mL 
(viscometric wheat arabinoxylan 
method)  
OR 
min 800 DNS units/mL (DNS 
birchwood xylan method) 
-        
Viscosimetric wheat 
arabinoxylan method or 
DNS birchwood 
method to determine 
xylanase  
 
Viscosimetric barley-β-
glucan or DNS barley-
β-glucan to determine 
β-glucanase  
 
Trade name (if appropriate)  ROVABIO® EXCEL  
Name  of  the  holder  of 
authorisation (if appropriate)  ADISSEO FRANCE SAS 
 
 Rovabio
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Conditions of use 
Species  or 
category  of 
animal 
Maximum Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  Units of activity/kg of complete feedingstuffs   
Lactating 
Sows        
Endo-1,3(4)-β-
glucanase: 1500 U 
Endo-1,4-β-xylanase: 
1100 U viscosimetric 
units  
-  - 
 
Other provisions and additional requirements for the labelling 
Specific  conditions  or  restrictions 
for use (if appropriate)  -   
Specific  conditions  or  restrictions 
for handling (if appropriate)  - 
Post-market monitoring  
(if appropriate)  -  
Specific  conditions  for  use  in 
complementary feedingstuffs  
(if appropriate) 
1. Recommended dose per kg of complete feedingstuff: endo-1,3(4)-
beta-glucanase: 1 500 U endo-1,4-beta-xylanase: 1 100 U  
2.  For  use  in  compound  feed  rich  in  non-starch  polysaccharides, 
(mainly betaglucans and arabinoxylans), e.g. containing more than 50 
% cereals (wheat, barley, corn…)  
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content 
in tissues 
-  -  -  - 
 Rovabio
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ASSESSMENT 
1.  Introduction 
The additive Rovabio
® Excel is a preparation of endo-1,3(4)-glucanase (EC 3.2.1.6; glucanase) and 
endo-1,4-beta-xylanase  (EC  3.2.1.8;  xylanase)  which  is  available  in  solid  and  liquid  forms.  The 
European Food Safety Authority (EFSA) issued an opinion on the safety and efficacy of Rovabio
® 
Excel as a feed additive for chickens and turkeys for fattening, laying hens, piglets (weaned) and pigs 
for fattening, ducks, guinea fowl, quails, geese, pheasants and pigeons (EFSA FEEDAP Panel, 2013). 
The full description of the formulations, manufacturing processes, purity, stability and homogeneity of 
the product is described in that assessment. The applicant is now requesting for an extension of the use 
of the product to lactating sows as a zootechnical additive under the functional group of digestibility 
enhancers. The FEEDAP Panel considers that the safety aspects, other than for the new target species, 
are covered in the previous assessment (EFSA FEEDAP Panel, 2013) and would not be affected by 
the requested extension of use. Therefore, the present opinion focuses only on the safety and efficacy 
of this enzyme preparation for the new target species. 
The additive is to be used in feed for lactating sows at a dose of 1 500 glucanase U and 1 100 xylanase 
U/kg feed (measured as viscosimetric units) in order to minimise the mobilisation of body reserves 
(e.g. reduce body weight loss or back-fat loss throughout lactation). 
2.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
The EURL considered that the conclusions and recommendations reached in a previous assessment are 
valid and applicable for the current application.
8 
3.  Safety for the target species 
A tolerance study was conducted using 40 sows (Duroc   Landrace; initial weight 300 kg) from four 
consecutive production batches.
9 The study took place from three weeks before farrowing until piglet 
weaning (day 28 of lactation). The sows were assigned to three dietary treatments (n = 13 or 14 sows, 
initial number).  Gestation and lactation diets,   based on wheat  and rye,  were supplemented with 
Rovabio
®  Excel  AP  to  provide  (glucanase/xylanase)  0/0,  3 000/2 200  (2   recommended  dose)  or 
300 000/220 000 (200  recommended dose) U/kg feed. Enzyme recoveries in the experimental diets 
were confirmed by analysis (mean activity double the intended). Feed was offered as pellets (pelleting 
temperature 60 °C) and was restricted during gestation (depending on the body condition of the sow) 
and was gradually increased during lactation to reach ad libitum level, provided twice daily. Cross-
fostering of piglets was applied at < 3 days of age to standardise the litter size. Piglets were offered 
creep feed. 
Sows were weighed at the start of the trial, in the last week of gestation, after farrowing (day 2) and at 
piglet weaning. Weight gain/loss was calculated. Individual feed intake of the sows was monitored 
weekly.  Measurement  of  the  back-fat  thickness  and  body  condition  scoring  was  conducted  at 
farrowing  and  weaning.  At  weaning,  blood  samples  were  obtained  from  all  the  sows  to  analyse 
haematological
10 and biochemical
11 parameters. Lactation performance was monitored. An analysis of 
variance (ANOVA) was performed on the data obtained, with the sow considered as the experimental 
unit. The effect of the batch/lot, sow’s parity number and treatment were considered in the model. Co-
                                                       
8  The  full  report  is  available on  the  EURL  website:  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2010-0189.pdf 
9  Technical dossier/Supplementary information January 2014/Annex i-1. 
10 Including: red blood cells, anisocytosis index, packed cell volume,  mean corpuscular volume, haemoglobin, mean 
corpuscular haemoglobin, corpuscular haemoglobin concentration, white blood cell, eosinophils basophil, band neutrophil, 
segmented neutrophil, lymphocyte and monocyte counts. 
11 Including: aspartate aminotransferase, alanine aminotransferase, gamma -glutamyl transpeptidase, alkaline phosphatase,  
calcium and phosphorus. Rovabio
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variables were also considered in the model for the measurements taken from the litter. Means were 
compared by Fisher’s least significant difference (LSD) test. 
Three  sows,  two  from  the  two-fold  group  and  one  from  the  200-fold  group,  required  antibiotic 
treatment owing to mastitis metritis agalactia syndrome and were removed from the study. Feed intake 
of the sows during lactation (average 5.1 kg/day), sows’ body weight at farrowing and at weaning, 
sow’s  body  weight  changes  (gestation  and  lactation)  and  the  litter’s  performance  were  not 
significantly  different  between  treatments.  Sows’  body  condition  score  and  back-fat  loss  during 
lactation was not modified by the treatments; however, the control group had initial values that were 
lower than those of the other two treatment groups. 
Haematological profile and biochemical blood parameters of the sows at weaning were, in general, not 
different  between  the  treatments.  The  only  modification  found  was  in  the  calcium  concentration, 
which was higher in the sows  receiving 200  the recommended dose  than in those receiving the 
control diet (97.5 mg/L vs. 92.4 mg/L), but these values remained within the physiological range for 
sows. Therefore, the Panel considers that the additive Rovabio
® Excel is safe for lactating sows at the 
recommended dose. 
4.  Efficacy 
A total of nine efficacy trials were assessed. Four of them were not considered any further owing to 
limitations in the design of the experiment. One trial was not considered because the sows received the 
additive from insemination until the end of the second weaning period.
12 For this study, the applicant 
also provided statistical analysis of the data from sows that were  studied for one reproductive cycle 
only.
13 However, the duration of the study was not in accordance with the conditions of use. The other 
three trials
14 were not considered in the assessment because their durations were shorter than 28 days 
and therefore did not follow the requirements established in the EFSA Guidance on tolerance and 
efficacy trials in target animals (EFSA FEEDAP Panel, 2011). 
The other five trials, described below, had a minimum duration of 28 days. Between the trials , the 
duration of the treatment during gestation ranged from seven to 28 days. The duration of the treatment 
during lactation ranged from 21 to 34 days. 
Trial 1 
A total of 125 sows (parity > 1, C22   PIC commercial breed) were allocated to a total of five dietary 
treatments, representing 25 replicates per treatment.
15  The sows  were  entered into the study in 
different batches. Three treatments were obtained by supplementing a lactation diet, based on wheat, 
barley and soya bean meal fulfilling the sow’s nutritional requirements (ST), with Rovabio
® Excel AP 
to provide (glucanase/xylanase) 0/0, 1 500/1 100 or 15 000/11 000 U/kg feed. Xylanase was measured 
(1 143 and 14 403 U/kg feed), whereas glucanase was calculated (1 966 and 24 773, using a factor of 
1.72).
16 The other two treatments were obtained by supplementing a low-energy/low-protein diet (L), 
based on wheat, barley and soya bean meal, with Rovabio
® Excel AP to provide (glucanase/xylanase) 
0/0  or  1 500/1 100 U/kg  feed.  Xylanase  was  measured  (1 272 U/kg  feed),  whereas  glucanase  was 
calculated  (2 188 U/kg,  applying  a  factor  of  1.72).  The  sows  received  the  diets  in  mash  form  a 
minimum of a one week before farrowing and until weaning, with a lactation duration of 21 days. 
Parameters  measured  included  sows’  body  weights  and  back-fat  (at  P2  level)  before  and  after 
farrowing and at weaning; feed intake during lactation (after reaching ad libitum level); and lactation 
performance in terms of litter weight gain and number of piglets. No information on the statistical 
analysis was provided. The results are presented in Table 2. 
                                                       
12 Technical dossier/Section IV/Annex IV.2. 
13 Technical dossier/Supplementary information January 2014/Annex ii.1 and Supplementary information April 2014/Annex 
i.1. 
14 Technical dossier/Section IV/Annexes IV.3, IV.4 and IV.6 and Supplementary information January 2014. 
15 Technical dossier/Section IV/Annex IV.5 and Supplementary information January 2014. 
16 For details on the factor, please see EFSA FEEDAP Panel (2013). Rovabio
® Excel for sows 
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Table 2:   Effect of Rovabio
® Excel on the body condition of sows, lactation feed intake and litter 
performance 
Basal 
diet
1 
Rovabio
® Excel 
(U/kg)
2 
Body condition modification 
during lactation  Sows’ feed 
intake during 
lactation  
(kg) 
Litter performance 
at weaning 
Body weight 
(kg) 
Back-fat 
(mm) 
Number 
of piglets 
Piglets’ 
weight 
(kg/pig) 
ST  0/0  –23.8  –5.9  104  10.0  6.23 
ST  1 500/1 100  –22.1  –5.0  111  10.0  6.47 
ST  15 000/11 000  –20.3  –5.0  109  10.0  6.03 
L  0/0  –19.4  –5.3  112  10.2  6.04 
L  1 500/1 100  –18.8  –5.7  109  10.0  6.25 
1  ST basal diet fulfils the sows’ nutritional requirements, L diet is a low-energy and low-protein diet. 
2  Glucanase/xylanase units per kg feed. 
Supplementation of either diet with Rovabio
® Excel did not result in any significant effect on any of 
the parameters measured. 
Trial 2 
This trial followed the same experimental design as the previous one but only included first parity 
sows.
17 Xylanase activity was measured in the diets and glucanase was calculated. The analysis of the 
diets showed a higher enzyme activity  than the intended (1 318–1 675 U xylanase/kg, ~ 35 % higher 
than the intended). In this trial, a digestibility study including the study of the digestibility of dry 
matter (DM), organic matter (OM) and of the gross energy (GE) was performed. Acid-insoluble ash 
was used as a marker and faecal samples were collected for three days. The results are presented in 
Table 3. 
Table 3:   Effect  of  Rovabio
®  Excel  on  the  body  condition  of  sows,  lactation  feed  intake,  litter 
performance and gross energy digestibility 
Basal 
diet
1 
Rovabio
® 
Excel  
(U/kg)
2 
Body condition 
modification during 
lactation  Sows’ feed 
intake during 
lactation (kg) 
Litter performance at 
weaning  Gross 
energy 
digestibility 
(%) 
Body 
weight  
(kg) 
Back-fat 
(mm) 
Number 
of piglets 
Piglets’ 
weight 
(kg/pig) 
ST  0/0  –6  –2.5  125  10.7  5.7  55.2 
ST  1 500/1 100  –7  –2.7  125  10.3  5.6  60.7* 
ST  15 000/11 000  –9  –3.4  119  10.9  6.0  57.6 
L  0/0  –8  –3.6  126  10.2  5.9  55.6 
L  1 500/1 100  –12  –3.1  126  10.5  5.8  59.8* 
1  ST basal diet fulfils the sows’ nutritional requirements, L diet is a low-energy and low-protein diet. 
2  Glucanase/xylanase units per kg feed. 
* Values are statistically different from the corresponding control group (P <0.05). 
Supplementation of either diet with Rovabio
® Excel did not result in any significant effect on the body 
condition of the sows, the feed intake during lactation or the litter performance parameters measured. 
The results showed a significant increase in faecal digestibility of DM, OM (data not shown) and GE 
when Rovabio
® Excel was added to the diet at the recommended dose. 
 
                                                       
17 Technical dossier/Supplementary information January 2014/Question ii/ ii-e/Annex ii.5. Rovabio
® Excel for sows 
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Trial 3 
A  total  of  20  sows  (parity  4  to  6,  commercial  breed)  were  allocated  to  two  dietary  treatments, 
representing  10  replicates  per  treatment.
18  Gestation and lactation diets ,  based on  maize, wheat 
middlings  and  soya  bean  meal ,  were  supplemented  with  Rovabio
®  Excel  AP  to  provide 
(glucanase/xylanase) 0/0 or 1 500/1 100 U/kg feed. Xylanase was measured (1 216 U/kg feed) and 
glucanase was calculated (2 092 U/kg feed, using a ratio of 1.72). The sows received the diets from 
one month before farrowing until weaning, with a lactation duration of 34 days. Sows were fed 1 kg 
feed per day during the gestation and then after, in lactation, on an ad libitum basis. Parameters 
measured included sows’ body weights before and after farrowing and at weaning, feed intake during 
lactation  and  farrowing,  and  lactation  performance.  Piglets  may  have  received  creep  feeding  (no 
details). No information on the statistical analysis was provided. The results are presented in Table 4. 
Table 4:   Effect of Rovabio
® Excel on the body condition of sows, lactation feed intake and litter 
performance 
Rovabio
® 
Excel  
(U/kg)
1 
Sows’body weight 
change during 
lactation  
(kg) 
Sows’ feed intake during 
lactation  
(kg/day) 
Litter performance at weaning 
Number of piglets  Piglets’ weight 
(kg/pig) 
0/0  –23.3  4.40  9.3  7.4 
1 500/1 100  –17.9  4.43  9.3  7.4 
1  Glucanase/xylanase units per kg feed. 
Supplementation with Rovabio
® Excel did not result in any significant effect on any of the parameters 
measured. 
Trial 4 
A total of 122 sows (parity 1 to 7, Large White   Landrace, OSP, ADN) were allocated to a control or 
a supplemented diet, representing 59 and 63 replicates per treatment, respectively.
19 The sows were 
included in the study in a total of nine batches. The basal diets, gestation and lactation diets, based on 
cereals, soya bean meal and sunflower meal, were supplemented with Rovabio
® Excel AP to provide 
(glucanase/xylanase) 0/0 or 1 500/1 100 U/kg feed. Xylanase was analysed (1 226 U/kg feed), whereas 
glucanase was calculated (2 109 U/kg feed, using a ratio of 1.72). The sows received the diets from six 
days before farrowing until weaning, with a lactation duration of 28 days. Sows were fed 2.5 kg feed 
per  day  during  the  gestation.  Three  days  after  farrowing,  sows  were  fed  on an  ad  libitum  basis. 
Parameters measured included sows’ body weight, back-fat (at P2 level) and depth of longissimus 
dorsi muscle (at P2 level) before and after farrowing and at weaning; feed intake during lactation and 
farrowing; and lactation performance. Litters were standardised after farrowing. Piglets received creep 
feeding from day 15 onwards. The results are presented in Table 5. 
Table 5:   Effect of Rovabio
® Excel on the body condition of sows, lactation feed intake and litter 
performance 
Rovabio
® 
Excel 
(U/kg)
1 
Body condition modification during 
lactation  Sows’ feed 
intake during 
lactation 
(kg/day) 
Litter performance at 
weaning 
Body 
weight  
(kg) 
Back fat 
(mm) 
Muscle 
depth  
(mm) 
Number of 
weaned 
piglets 
Piglets’ 
weight  
(kg) 
0/0  –27  –3.8  –8.1  5.8  11.4  8.2 
1 500/1 100  –24  –3.6  –7.4  6.1  11.4  8.4 
1  Glucanase/xylanase units per kg feed. 
                                                       
18 Technical dossier/Section IV/Annex IV.7 and Supplementary information January 2014/Question ii/ii-c/Annex ii.2. 
19 Technical dossier/Section IV/Annex IV.8 and Supplementary information January 2014. Rovabio
® Excel for sows 
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The results showed no modifications on the parameters studied when Rovabio
® Excel was added to the 
diet at the recommended dose. 
Trial 5 
A total of 157 sows (parities 1 to 10, Duroc   Landrace) were allocated to two dietary treatments 
(n = 76 or 81 sows, initial number).
20 The sows were included in the study in a total of 12  batches. 
During gestation, the sows were housed in dynamic groups fed a common commercial diet until three 
weeks before farrowing, at which time the sows were assigned to the different experimental groups. 
One week before farrowing, the sows were moved to the lactation barn. Gestation and lactation diets, 
based on wheat and rye, alfalfa meal/sunflower meal (gestation) or soya bean meal (lactation), were 
supplemented with Rovabio
® Excel AP to provide (glucanase/xylanase) 0/0 or 1 500/1 100 U/kg feed. 
Xylanase and glucanase activities were  measured, 1 558/2 900 U/kg feed in the gestation diet and 
1 505/3 069 U/kg  feed  in  the  lactation  diet.  The  study  was  performed  from  three  weeks  before 
farrowing until weaning, with a lactation duration of 28 days. Feed was offered in pelleted (pelleting 
temperature 60 °C) form, which was restricted during gestation (depending on the body condition of 
sows), but during lactation was gradually increased to reach an ad libitum level provided twice daily. 
Cross-fostering of piglets was applied before three days of age. Piglets were offered creep feed (no 
details). Sows were weighed at the start of the trial, on the last week of gestation, after farrowing and 
after weaning. Weight gain/loss was calculated. Individual feed intake during lactation was monitored 
every  week.  Measurement  of  the  back-fat  thickness  (P2  level)  and  body  condition  scoring  were 
conducted  at  farrowing  and  weaning.  The  number  of  piglets  and  the  weight  of  the  litters  were 
monitored during lactation and at weaning. An ANOVA was performed with the data considering 
batch, parity and diet. The results are presented in Table 6. 
Table 6:   Effect of Rovabio
® Excel on the body condition of sows, lactation feed intake and litter 
performance 
Rovabio
® Excel  
(U/kg) 
1 
Body condition modification 
during lactation  Sows’ feed intake 
during lactation 
(kg/day) 
Litter performance at weaning 
Body weight  
(kg) 
Back fat  
(mm) 
Number of 
piglets 
Piglets’ 
weight 
(kg/pig) 
0/0  –25.8  –4.1  5.60  10.4
a  8.41 
1 500/1 100  –22.4  –3.4  5.35  9.7
b  8.31 
1  Glucanase/xylanase units per kg feed. 
a,b  Values within a column with a different superscript are different (P < 0.05). 
 
The results showed no modifications on the parameters studied when Rovabio
® Excel was added to the 
diet at the recommended dose, except a lower number of piglets weaned in the Rovabio
® Excel group. 
Meta-analysis 
There were no significant positive effects in the individual trials. The data from the five trials were 
pooled and a statistical analysis was performed.
21 The analysis included the data from 505 sows. The 
data studied included sows’ weight (all five studies) and back-fat thickness (only in four studies, not 
measured  in  trial  5)  after  farrowing  and  weaning,  weight  loss  and  feed  intake  during  lactation, 
farrowing performance and litter performance during lactation. 
The data were evaluated with an ANOVA mixed model and the dietary treatment was considered as a 
fixed effect, the parity was considered as a blocking fixed factor and the trial was considered as a 
random  effect.  As  no  significant  interaction  between  treatment  and  parity  was  detected  for  body 
weight after farrowing, body weight at weaning, body weight loss (P = 0.06) and feed intake of the 
                                                       
20 Technical dossier/ Supplementary information January 2014/Question ii/ ii-e/Annex ii.3. 
21 Technical dossier/Supplementary information April 2014/Question i-2/Annex i.2. Rovabio
® Excel for sows 
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sows, this term was removed from the model. Tests of homogeneity were carried out with the data. 
The results are presented in the Table 7. 
Table 7:   Effect of Rovabio
® Excel on the body condition of sows, lactation feed intake and litter 
performance with data pooled from five different studies 
Rovabio
® 
Excel  
(U/kg)
1 
Body condition modification 
during lactation  Sows’ feed intake 
during 
lactation(kg/day) 
Litter performance at weaning 
Body weight 
(kg) 
Back fat 
(mm) 
Number of 
piglets 
Piglets’ 
weight  
(kg) 
0/0  –21.6
a  –4.2  5.51  10.6  7.29 
1 500/1 100  –19.0
b  –3.9  5.55  10.2  7.36 
1  Glucanase/xylanase units per kg feed. 
a,b  Values within a column with a different superscript are different (P < 0.05). 
 
The results of the meta-analysis showed that supplementing sows’ diets with Rovabio
® Excel at the 
recommended dose resulted in a statistically significant lower body weight loss of the sows during 
lactation, without affecting the other parameters evaluated. Sows fed Rovabio
® Excel lost 2.6 kg less 
weight  during  lactation  than  control  sows  (mean  body  weight  at  weaning = 233 kg).  The 
biological/physiological relevance of this finding is questionable, especially considering the potential 
impact of this reduction on the following weaning to oestrus interval and on the next reproductive 
cycle of the sows (no data available). 
4.1.  Conclusions on the efficacy 
The results of the meta-analysis showed a significant but very limited reduction in sows’ body weight 
loss during lactation when fed Rovabio
® Excel at the recommended dose from at least one week 
before farrowing and during the whole lactation period, which may indicate some potential of the 
additive  to  be  efficacious.  However,  the  FEEDAP  Panel  questions  the  biological/physiological 
relevance of this finding, especially considering that the impact on the following weaning to oestrus 
interval and on the next reproductive cycle of the sows was not measured. In one trial, a significant 
increase was noted in the faecal digestibility of the energy of the diet containing Rovabio
® Excel at a 
higher dose than that recommended. The FEEDAP Panel cannot conclude on the efficacy of Rovabio
® 
Excel in lactating sows from the data currently available. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
22  and  Good 
Manufacturing Practice. 
CONCLUSIONS 
The liquid and solid forms of the product are considered to be equivalent in terms of safety and 
efficacy of the product. 
The results of a tolerance study showed that 200-fold the recommended dose was tolerated well by the 
sows when offered for a period of seven weeks, including gestation and lactation. Therefore, the Panel 
concludes that the recommended dose is safe in lactating sows. 
Based  on  the  efficacy  studies  provided,  the  FEEDAP  Panel  cannot  conclude  on  the  efficacy  of 
Rovabio
® Excel in lactating sows. 
                                                       
22 Regulation  (EC)  No  183/2005  of  the  European  Parliament  and  of  the  Council  of  12  January  2005  laying  down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Rovabio
® Excel for sows 
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